Saturday, January 17, 2026
HomeNews

News

AbbVie and Gilgamesh Pharmaceuticals Announce Collaboration and Option-to-License Agreement to Develop Next-Generation Therapies for Psychiatric Disorders

AbbVie and Gilgamesh Pharmaceuticals announced a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in...

Oklo Signs MOU with Atomic Alchemy to Collaborate on Isotope Production

Oklo Inc., a fast fission clean power technology and nuclear fuel recycling company, is forming a strategic partnership with Atomic Alchemy Inc. to produce...

Clarios Formalizes Joint Development Agreement with Sodium-Ion Battery Developer Altris

Clarios, a global leader in advanced battery solutions and Altris, a Swedish developer and prototype manufacturer of sodium-ion batteries, announced an exclusive Joint Development...

GSE Solutions Appoints Damian DeLongchamp as Chief Operating Officer

GSE Solutions, a leader in advanced engineering and workforce solutions that supports the future of clean-energy production and decarbonization initiatives of the power industry,...

NASA Named David Salvagnini as a First Chief Artificial Intelligence Officer

NASA Administrator Bill Nelson named David Salvagnini as the agency's new chief artificial intelligence (AI) officer, effective immediately. The role is an expansion of Salvagnini's current...
0FansLike
0FollowersFollow
spot_img

Hot Topics